We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+33.48%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$611M
AUM Growth
+$11.7M
Cap. Flow
-$91.9M
Cap. Flow %
-15.04%
Top 10 Hldgs %
4.77%
Holding
1,794
New
573
Increased
263
Reduced
313
Closed
643

Top Buys

Rank Stock Value
1
BBY icon
Best Buy
BBY
+$2.79M
2
BBWI icon
Bath & Body Works
BBWI
+$2.78M
3
AMD icon
Advanced Micro Devices
AMD
+$2.7M
4
NVDA icon
NVIDIA
NVDA
+$2.4M
5
XOM icon
ExxonMobil
XOM
+$2.28M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.42%
2 Technology 16.03%
3 Healthcare 14.17%
4 Industrials 13.91%
5 Financials 11.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LVO icon
451
LiveOne
LVO
$58.2M
$477K 0.08%
14,557
+2,304
+19% +$56.1K
MSI icon
452
Motorola Solutions
MSI
$77.4B
$476K 0.08%
+2,801
New +$470K
AAL icon
453
American Airlines Group
AAL
$10.6B
$475K 0.08%
+30,109
New +$417K
RRX icon
454
Regal Rexnord
RRX
$11.9B
$475K 0.08%
3,866
-5,349
-58% -$591K
AGX icon
455
Argan
AGX
$8.37B
$473K 0.08%
+10,639
New +$477K
PHAS
456
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$472K 0.08%
140,341
-13,975
-9% -$50K
COST icon
457
Costco
COST
$420B
$470K 0.08%
1,247
+625
+100% +$234K
PH icon
458
Parker-Hannifin
PH
$135B
$470K 0.08%
1,727
-839
-33% -$208K
AAIC
459
DELISTED
Arlington Asset Investment Corp.
AAIC
$469K 0.08%
124,058
+15,202
+14% +$47.5K
TXMD icon
460
TherapeuticsMD
TXMD
$24M
$466K 0.08%
7,702
+5,956
+341% +$407K
ADTN icon
461
Adtran
ADTN
$616M
$465K 0.08%
31,506
-33,563
-52% -$426K
DSGR icon
462
Distribution Solutions Group
DSGR
$1.61B
$465K 0.08%
18,282
-168
-0.9% -$4K
TT icon
463
Trane Technologies
TT
$106B
$465K 0.08%
+3,200
New +$442K
CFR icon
464
Cullen/Frost Bankers
CFR
$10.2B
$464K 0.08%
+5,315
New +$418K
BANR icon
465
Banner Corp
BANR
$2.4B
$463K 0.08%
9,948
-5,288
-35% -$218K
PACW
466
DELISTED
PacWest Bancorp
PACW
$459K 0.08%
18,090
+1,914
+12% +$42.7K
MYE icon
467
Myers Industries
MYE
$1.29B
$458K 0.07%
22,055
+1,040
+5% +$17.3K
SRI icon
468
Stoneridge
SRI
$213M
$457K 0.07%
15,106
-3,520
-19% -$91.2K
WLK icon
469
Westlake Corp
WLK
$9.9B
$457K 0.07%
5,604
-1,867
-25% -$139K
RCL icon
470
Royal Caribbean
RCL
$85.6B
$456K 0.07%
+6,100
New +$425K
UNH icon
471
UnitedHealth
UNH
$370B
$456K 0.07%
1,299
+68
+6% +$22.8K
LOGC
472
DELISTED
ContextLogic
LOGC
$456K 0.07%
+833
New +$514K
CASY icon
473
Casey's General Stores
CASY
$30.9B
$455K 0.07%
2,545
-1,451
-36% -$263K
FHI icon
474
Federated Hermes
FHI
$4.72B
$455K 0.07%
15,747
-6,968
-31% -$185K
IBKR icon
475
Interactive Brokers
IBKR
$39.8B
$455K 0.07%
29,876
+5,380
+22% +$71.3K

Similar funds

GSA Capital Partners's Q4 2020 Portfolio in Review

As of Q4 2020, GSA Capital Partners held 1,794 positions worth $611M, up 2% from $600M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.

GSA Capital Partners withdrew a net $91.9M in Q4 2020, closing 643 positions and reducing 313 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $10.9M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

Against the trend, GSA Capital Partners opened a new position in Best Buy worth $2.49M.

  • GSA Capital Partners's largest Q4 2020 buy was Best Buy: 24,945 shares worth $2.49M.
  • GSA Capital Partners added most to Advanced Micro Devices in Q4 2020, an estimated $2.7M increase.
  • GSA Capital Partners's biggest Q4 2020 reduction was BridgeBio Pharma, cutting an estimated $3.35M.
  • GSA Capital Partners fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2020, selling an estimated $10.9M.
  • GSA Capital Partners's ten largest holdings make up 4.8% of its $611M portfolio in Q4 2020.
  • GSA Capital Partners opened 573 new positions and closed 643 in Q4 2020.
  • GSA Capital Partners's portfolio value rose 2% quarter-over-quarter to $611M.

Based on GSA Capital Partners's 13F filing for Q4 2020, filed 3 Feb 2021.